PBPK modeling of irbesartan: incorporation of hepatic uptake.
about
Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.Role of Hepatic Drug Transporters in Drug Development.
P2860
PBPK modeling of irbesartan: incorporation of hepatic uptake.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
PBPK modeling of irbesartan: incorporation of hepatic uptake.
@en
type
label
PBPK modeling of irbesartan: incorporation of hepatic uptake.
@en
prefLabel
PBPK modeling of irbesartan: incorporation of hepatic uptake.
@en
P2093
P2860
P356
P1476
PBPK modeling of irbesartan: incorporation of hepatic uptake
@en
P2093
Helene Chapy
Olivier Nicolas
Priscilla Brun
Sylvie Klieber
Xavier Boulenc
P2860
P304
P356
10.1002/BDD.1961
P577
2015-08-03T00:00:00Z